Polish I · High-ROI Weak Points
Your weakpoints (ChatGPT finals review) × the high-yield analysis. Drill in ROI order: kinetics, folate/B12/one-carbon, purines/pyrimidines, lipoproteins (Tier 1) · AA/urea, PPP, cholesterol (Tier 2) · vitamins+cofactors, mol bio (quick points). Colored to the study-book guide.
Study this deck free Add to my library
- FrontKm equals the substrate concentration at what fraction of Vmax ?Back[S] at ½ Vmax . Low Km = high affinity ; high Km = low affinity .
- FrontWhich enzyme parameter is the turnover number — molecules of substrate converted per second by one saturated enzyme, independent of [E]?Backkcat . Intrinsic to the enzyme. Contrast: Vmax = kcat × [E]total , which scales with enzyme amount.
- FrontWrite the equation linking Vmax , kcat , and total enzyme .BackVmax = kcat × [E]total . Double the enzyme → double the Vmax; kcat is unchanged (intrinsic).
- FrontWhich single ratio expresses catalytic efficiency (performance at low, non-saturating [S] )?Backkcat / Km . Diffusion-limited ceiling ≈ 10⁸–10⁹ M⁻¹s⁻¹ .
- FrontCompetitive inhibitor — effect on Km and Vmax ?BackKm UP (apparent), Vmax SAME . Inhibitor resembles substrate and fights for the active site .
- FrontReversible inhibitor: Km increased , Vmax unchanged . Which type?BackCompetitive . The only reversible type that spares Vmax .
- FrontNoncompetitive inhibitor — effect on Km and Vmax ?BackKm SAME , Vmax DOWN . Binds an allosteric site , not the active site; ES still forms but ESI can't turn over.
- FrontReversible inhibitor: Vmax decreased , Km unchanged . Which type?BackNoncompetitive (kinetically identical to irreversible ). Cannot be rescued by excess substrate.
- FrontUncompetitive inhibitor — effect on Km and Vmax ?BackKm DOWN and Vmax DOWN (both, by the same factor). Inhibitor binds only the ES complex .
- FrontInhibitor with Km DOWN and Vmax DOWN (both decrease) — which type?BackUncompetitive . Binds ES only → traps it as dead-end ESI, lowering apparent Km while killing Vmax.
- FrontAn inhibitor binds only to the ES complex (not free enzyme). Name the type and its LB signature.BackUncompetitive . On Lineweaver-Burk: parallel line (slope unchanged), shifted up and to the left .
- FrontOn a Lineweaver-Burk plot, the y-intercept = ? and the x-intercept = ?Backy-intercept = 1/Vmax ; x-intercept = −1/Km . Trap: a higher y-intercept means a lower Vmax (reciprocal).
- FrontCompetitive inhibition on Lineweaver-Burk — how do the intercepts move?Backy-intercept SAME (1/Vmax unchanged); x-intercept shifts right toward 0 (less negative → larger apparent Km). Slope increases ; line rotates about the y-intercept .
- FrontNoncompetitive inhibition on Lineweaver-Burk — how do the intercepts move?Backx-intercept SAME (−1/Km unchanged); y-intercept rises (1/Vmax up → lower Vmax). "Same x-intercept, different y-intercept" = noncompetitive .
- FrontLineweaver-Burk: line has the same x-intercept but a higher y-intercept than control. Which inhibition?BackNoncompetitive — same x-intercept = same Km ; higher y-intercept = lower Vmax .
- FrontLineweaver-Burk: line has the same y-intercept but a less-negative x-intercept than control. Which inhibition?BackCompetitive — same y-intercept = same Vmax ; x-intercept toward 0 = higher apparent Km .
- FrontLineweaver-Burk: inhibited line is parallel to control, shifted up and left. Which inhibition?BackUncompetitive — slope unchanged, both Km and Vmax down. "Parallel lines" is the mnemonic.
- FrontCan competitive inhibition be overcome by adding more substrate ?BackYes — flood with substrate to out-compete the inhibitor; Vmax is reached. (Noncompetitive and uncompetitive: cannot be rescued.)
- FrontHow does an irreversible inhibitor differ from noncompetitive on kinetics alone — and the real distinction?BackKinetically identical: Vmax down , Km unchanged . Distinction: irreversible forms a covalent bond — washing out the inhibitor or adding substrate does NOT restore activity; recovery needs new enzyme synthesis.
- FrontWhat is the central carrier of one-carbon units that the entire one-carbon economy runs on?BackTetrahydrofolate (THF) — the reduced, active form of folate (vitamin B9) .
- FrontWhich enzyme reduces dietary folate → DHF → THF , and what reducing cofactor does it use?BackDihydrofolate reductase (DHFR) , using NADPH . (Blocked by methotrexate .)
- FrontWhich THF derivative is the major source of one-carbon units , and which reaction produces it?BackN5,N10-methylene-THF — produced by the serine → glycine reaction via serine hydroxymethyltransferase (SHMT) (needs PLP + THF).
- FrontN5,N10-methylene-THF is consumed by which enzyme , to make which product for DNA?BackThymidylate synthase converts dUMP → dTMP , oxidising THF to DHF (which DHFR must regenerate).
- FrontWhich THF derivative is the methyl donor used to regenerate methionine from homocysteine ?BackN5-methyl-THF — donates its methyl group to homocysteine via methionine synthase .
- FrontWhich enzyme regenerates methionine from homocysteine , and which vitamin cofactor does it require?BackMethionine synthase — requires vitamin B12 (methylcobalamin) , using N5-methyl-THF as the methyl donor.
- FrontMethionine synthase transfers a methyl group FROM which donor TO which acceptor?BackFROM N5-methyl-THF → TO homocysteine , regenerating methionine (+ freeing THF ).
- FrontWhy can N5-methyl-THF NOT simply be reconverted to other THF forms — what is its only exit?BackThe N5-methyl-THF → THF step is essentially irreversible ; its only exit is through methionine synthase (the B12 step). This is the structural basis of the folate trap .
- FrontB12 deficiency : in which single THF form does folate get stranded , and what is this called?BackFolate is trapped as N5-methyl-THF — the methyl-folate trap . Without B12, methionine synthase stalls and THF can't be recycled into N5,N10-methylene-THF.
- FrontMechanistically, how does the folate trap cause megaloblastic anemia in B12 deficiency?BackTrapped N5-methyl-THF can't reform N5,N10-methylene-THF → no substrate for thymidylate synthase → no dTMP → DNA replication halts in erythroid precursors.
- FrontDeficiency of WHICH vitamin causes homocysteine accumulation ?BackEither B12 or folate — both feed the remethylation step (B12 runs methionine synthase; folate supplies N5-methyl-THF), so deficiency of either raises homocysteine .
- FrontBoth B12 deficiency and folate deficiency — which TWO findings do they SHARE?BackMegaloblastic anemia + elevated homocysteine . (The hematology and the homocysteine look identical.)
- FrontWhich finding is present in B12 deficiency but NOT in folate deficiency — and is the most sensitive marker?BackElevated methylmalonic acid (MMA) — only B12 deficiency raises it (folate is normal). More sensitive than serum B12 itself.
- FrontWhich B12-only clinical feature distinguishes it from folate deficiency ?BackNeurological signs — subacute combined degeneration of the spinal cord (demyelination). Folate deficiency alone causes NO neuro disease.
- FrontWhy does B12 deficiency raise methylmalonic acid but folate deficiency does not?BackB12 is also the cofactor ( 5'-deoxyadenosylcobalamin ) for methylmalonyl-CoA mutase ( methylmalonyl-CoA → succinyl-CoA ). Folate has no role here, so MMA stays normal in folate deficiency.
- FrontThe clinical pitfall : why is giving folate alone to a B12-deficient patient dangerous?BackFolate corrects the megaloblastic anemia but masks the underlying B12 deficiency — the neurological degeneration progresses unchecked . Always rule out B12 before treating with folate alone.
- FrontPurine de novo synthesis: the ring is built on what activated starting molecule ?BackPRPP (phosphoribosyl pyrophosphate). The purine ring is assembled atom-by-atom directly on the ribose scaffold of PRPP — opposite of pyrimidines.
- FrontRing assembled FIRST as a free molecule, THEN attached to PRPP — purines or pyrimidines? (classic trap)BackPyrimidines . Ring built free in the cytoplasm first, then bolted onto PRPP. (Purines = ring built on PRPP.)
- FrontWhich amino acid donates the amide nitrogen at the committed step of purine synthesis (and 2 N total to the ring)?BackGlutamine (Gln) — its amide N is used by PRPP amidotransferase to make 5-phosphoribosylamine .
- FrontPurine de novo: which enzyme catalyzes the committed/rate-limiting step?BackPRPP amidotransferase — converts PRPP → 5-phosphoribosylamine . Inhibited by AMP, GMP, IMP ; activated by PRPP .
- FrontPurine de novo committed step: PRPP amidotransferase — what activates it, what inhibits it?BackActivated by PRPP (substrate). Inhibited by the downstream products AMP, GMP, and IMP .
- FrontPurine branch point: which nucleotide is the common precursor from which both AMP and GMP diverge?BackIMP (inosine monophosphate). The whole 10-step de novo pathway converges on IMP before branching to AMP or GMP .
- FrontIMP → AMP : which energy nucleotide is consumed, and which amino acid is needed? (cross-dependency trap)BackNeeds aspartate and consumes GTP as the energy source. (Making AMP requires GTP — the elegant cross-dependency.)
- FrontIMP → GMP : which energy nucleotide is consumed, and which amino acid is needed?BackNeeds glutamine and consumes ATP as the energy source. (Making GMP requires ATP — mirror of the AMP branch.)
- FrontFolate cofactor needed at two steps of de novo purine ring assembly (donates 2 carbons)?BackFormyl-THF (N10-formyl-THF). This is why antifolates like methotrexate cripple purine synthesis too — not just pyrimidines.
- FrontPyrimidine de novo: which enzyme makes carbamoyl phosphate, and where?BackCPS-II (carbamoyl phosphate synthetase II), in the cytosol . Uses glutamine + CO2 + 2 ATP. Activated by PRPP , inhibited by UTP .
- FrontCPS-II vs CPS-I : which uses glutamine vs NH4+ , which compartment, which pathway?BackCPS-II : glutamine , cytosol , pyrimidine synthesis (activated by PRPP, inhibited by UTP). CPS-I : NH4+ , mitochondria , urea cycle (activated by N-acetylglutamate ).
- FrontPyrimidine de novo: the ring intermediate orotic acid is attached to PRPP, decarboxylated, and yields which mother pyrimidine nucleotide ?BackUMP . Orotate + PRPP → orotate monophosphate → (decarboxylation) → UMP , the parent of all pyrimidines (→ UDP → UTP → CTP).
- FrontWhich enzyme reduces ribonucleotides to deoxyribonucleotides, and at which phosphorylation level?BackRibonucleotide reductase (RNR) — acts at the NDP level (ADP/GDP/CDP/UDP → dNDPs). Reducing power from NADPH via thioredoxin.
- FrontRibonucleotide reductase activity site: what turns it completely OFF vs keeps it ON ?BackdATP turns RNR OFF ; ATP keeps it ON . (This is the lever behind ADA deficiency → SCID .)
- FrontdUMP → dTMP : which enzyme catalyzes it, and which cofactor donates the methyl group?BackThymidylate synthase , using N5,N10-methylene-THF as the methyl donor (oxidized to DHF in the process).
- FrontAfter thymidylate synthase runs, the folate is oxidized to DHF — which enzyme regenerates active THF, using what cofactor?BackDihydrofolate reductase (DHFR) , using NADPH . Without it the cycle stalls and dTMP production halts — the target of methotrexate .
- FrontMethotrexate — which enzyme does it inhibit, and what two pathways does that shut down?BackInhibits DHFR (~1000× tighter than DHF). No THF regenerated → blocks dTMP synthesis (no methylene-THF) AND de novo purine synthesis (no formyl-THF).
- Front5-Fluorouracil (5-FU) — its active metabolite F-dUMP is a suicide inhibitor of which enzyme ?BackThymidylate synthase . F-dUMP forms a covalent, irreversible ternary complex with the enzyme + methylene-THF , jamming dTMP synthesis.
- FrontDrug-to-target: name the enzyme hit by 5-FU and the one hit by methotrexate .Back5-FU → thymidylate synthase (via F-dUMP). Methotrexate → DHFR .
- FrontPurine salvage : which enzyme recycles hypoxanthine → IMP and guanine → GMP, and which disease is its complete deficiency?BackHGPRT (hypoxanthine-guanine phosphoribosyltransferase). Complete deficiency = Lesch-Nyhan syndrome (self-mutilation, choreoathetosis, hyperuricemia/gout).
- FrontLesch-Nyhan (HGPRT loss) causes hyperuricemia — by what mechanism (not just "less salvage")?BackNo salvage → PRPP accumulates → over-activates PRPP amidotransferase → de novo purine synthesis runs unchecked → degradation floods out excess uric acid . (Overproduction-type gout.)
- FrontPurine degradation: which enzyme oxidizes hypoxanthine → xanthine → uric acid (acts twice)?BackXanthine oxidase . Humans lack uricase, so uric acid is the terminal purine catabolite — the reason gout exists in humans.
- FrontXanthine oxidase — name its three cofactors .BackFAD , molybdenum (Mo) , and non-heme iron . (A flavoprotein — classic 'which mineral?' = molybdenum.)
- FrontGout treatment: allopurinol — what is it an analogue of, and which enzyme does it inhibit?BackA hypoxanthine analogue. Xanthine oxidase oxidizes it to alloxanthine (oxypurinol) , a suicide inhibitor of xanthine oxidase . Result: more-soluble hypoxanthine/xanthine accumulate instead of urate.
- FrontADA deficiency → SCID: trace the biochemical mechanism.BackNo ADA → dATP accumulates → turns ribonucleotide reductase OFF → no dNDP pools → lymphocytes can't replicate DNA → both T and B cells fail = SCID .
- FrontMost common cause of gout (~90% of cases) — overproduction or under-excretion?BackDecreased renal excretion of urate (~90%), NOT overproduction. (Overproduction types include Lesch-Nyhan and overactive PRPP synthetase.)
- FrontWhich lipoprotein carries the MOST cholesterol (is the cholesterol-delivery particle)?BackLDL — core is almost entirely cholesteryl esters ; delivers cholesterol to tissues.
- FrontWhich lipoprotein is TAG-rich and carries DIETARY fat from the gut, and what is its signature apolipoprotein?BackChylomicron — signature apo is ApoB-48 (intestine-only).
- FrontWhich apolipoprotein is found ONLY on chylomicrons and is made exclusively in the intestine?BackApoB-48 — synthesized only in intestinal enterocytes ; it cannot bind the LDL receptor (truncated, lacks the receptor-binding domain).
- FrontApoB-48 vs ApoB-100: tissue of origin, particles carried, and LDL-receptor binding for each?BackApoB-48 : intestine -only, chylomicrons only, cannot bind LDL receptor . ApoB-100 : liver -only, stays on VLDL→IDL→LDL, IS the LDL-receptor ligand .
- FrontWhich lipoprotein is TAG-rich, hepatic (endogenous) fat export , and which apo is its mandatory scaffold?BackVLDL — made by the liver with ApoB-100 as the obligatory structural scaffold; core is predominantly TAG .
- FrontWhich lipoprotein mediates reverse cholesterol transport , and what is its main apolipoprotein?BackHDL — main apo is ApoA-I ; carries cholesterol from peripheral tissues back to the liver.
- FrontWhich apolipoprotein activates lipoprotein lipase (LPL) , and where does it come from in circulation?BackApoCII — obligate activator of LPL ; donated to chylomicrons/VLDL from HDL , then returned to HDL. Without it, LPL sits idle and TAG cannot be cleaved .
- FrontWhich apolipoprotein is the ligand for remnant (chylomicron remnant / IDL) uptake by the liver?BackApoE — recognized by the liver's LDL receptor and LRP for receptor-mediated clearance of remnants and IDL.
- FrontReverse cholesterol transport: which enzyme esterifies free cholesterol in HDL, and what activates it?BackLCAT (lecithin:cholesterol acyltransferase), activated by ApoA-I — esterifies free cholesterol (fatty acid from lecithin/phosphatidylcholine ) so the cholesteryl ester sinks into the HDL core and matures the particle.
- FrontName the apolipoprotein for each particle (COLD): chylomicron, VLDL, LDL, HDL .BackChylomicron → ApoB-48 (+ApoCII, ApoE) VLDL → ApoB-100 (+ApoCII) LDL → ApoB-100 only HDL → ApoA-I (activates LCAT)
- FrontAfter VLDL→IDL→LDL remodeling, which apolipoprotein is the ONLY one left on LDL ?BackApoB-100 — LDL has lost all ApoCII and ApoE; only ApoB-100 remains (the LDL-receptor ligand).
- FrontRank the 4 lipoproteins by DENSITY (least → most dense). What inversely tracks with density?BackChylomicron < VLDL < LDL < HDL (least → most dense). SIZE is inverse : chylomicrons are largest, HDL smallest — more lipid relative to protein = larger and less dense (fat is lighter than protein).
- FrontWhich lipoprotein is the LARGEST and LEAST dense , and which is the SMALLEST and densest ?BackLargest / least dense = Chylomicron (TAG-rich, ~80–500 nm). Smallest / densest = HDL (high protein-to-lipid ratio).
- FrontWhich receptor clears LDL , what apo does it recognize, and what mechanism internalizes it?BackThe LDL receptor (B/E receptor) recognizes ApoB-100 ; uptake is by receptor-mediated endocytosis in clathrin-coated pits.
- FrontBoth chylomicrons and VLDL deliver TAG to peripheral tissues. Which enzyme strips the TAG, and which apo activates it?BackLipoprotein lipase (LPL) on capillary endothelium , activated by ApoCII — cleaves core TAG into free fatty acids + glycerol .
- FrontWhich protein transfers cholesteryl esters from HDL → LDL/VLDL (in exchange for TAG)?BackCETP (cholesteryl ester transfer protein) — moves cholesteryl esters from HDL to LDL/VLDL for eventual LDL-receptor clearance. (Contrast: LCAT esterifies; CETP transfers.)
- FrontFree cholesterol delivered by LDL regulates the cell in three ways — name them.Back(1) Suppresses HMG-CoA reductase (stops synthesis); (2) activates ACAT (re-esterifies cholesterol for storage); (3) downregulates the LDL receptor (limits further uptake).
- FrontThe remnant of a stripped chylomicron carries which apos, and which organ clears it via which apo?BackChylomicron remnant keeps ApoE + ApoB-48 ; the liver clears it via ApoE (LDL receptor + LRP). ApoCII and surface phospholipids are returned to HDL.
- FrontTransamination requires which coenzyme , and from which vitamin is it derived?BackPLP (pyridoxal phosphate) , the active form of vitamin B6 . It is the obligate coenzyme for every aminotransferase .
- FrontIn transamination, the amino group from most amino acids is transferred onto which acceptor , producing which product ?BackAcceptor = α-ketoglutarate ; product = glutamate . This funnels the nitrogen of virtually all amino acids into one hub .
- FrontWhich two amino acids do NOT undergo classical transamination?BackLysine and threonine — the two exceptions. (Trap: "all amino acids transaminate" is false .)
- FrontDefine transdeamination — its two steps and the enzymes/compartments.BackTransamination (by an aminotransferase , collects N onto glutamate ) + oxidative deamination (by glutamate dehydrogenase in the mitochondria , releases free NH4+ ). It is the major route of nitrogen removal .
- FrontWhich enzyme releases free NH4+ from glutamate, where, and reducing what cofactor ?BackGlutamate dehydrogenase (GDH) , a mitochondrial enzyme. It oxidizes glutamate → α-ketoglutarate + NH4+ , reducing NAD+ (or NADP+) to NADH. This is the primary source of free NH4+ in the liver .
- FrontHow is glutamate dehydrogenase allosterically regulated, and what does it sense?BackADP activates (energy-poor → catabolize amino acids); GTP inhibits (energy-rich → no need to burn amino acids). Ties nitrogen catabolism to cellular energy state .
- FrontWhich aminotransferase generates aspartate for the urea cycle, and by what reaction?BackAST (aspartate aminotransferase) — transfers an amino group from glutamate to oxaloacetate , making aspartate (the cycle's 2nd nitrogen donor).
- FrontOn a liver panel: which transaminase is more specific for liver damage vs more sensitive ?BackALT = more specific for liver. AST = more sensitive (very high activity inside hepatocytes ). Both rise with cell necrosis .
- FrontUrea cycle: which enzyme catalyzes the committed first step, and in which compartment ?BackCPS-I (carbamoyl phosphate synthetase I) , in the mitochondrial matrix of the liver .
- FrontWhat does CPS-I condense to form carbamoyl phosphate , and at what ATP cost?BackNH4+ + HCO3− → carbamoyl phosphate , consuming 2 ATP . This nitrogen becomes one of the two nitrogens in urea .
- FrontWhich activator is obligatory for CPS-I , and what happens without it?BackN-acetylglutamate (NAG) . Without it, CPS-I is completely inactive — no NAG = no carbamoyl phosphate = the entire cycle stops at step zero . (NAG synthesis is feed-forward activated by arginine .)
- FrontCPS-I vs CPS-II — distinguish by location and nitrogen source .BackCPS-I : mitochondrial , uses NH4+ , → urea. CPS-II : cytosolic , uses amide of glutamine , → pyrimidine synthesis . Mnemonic: CPS- I = m I tochondria; CPS- II = cytosol II c + glutam II ne.
- FrontCytosolic enzyme: makes carbamoyl phosphate for pyrimidine synthesis , uses glutamine , activated by PRPP , inhibited by UTP ?BackCPS-II .
- FrontUrea cycle Reaction 1: ornithine transcarbamoylase (OTC) combines carbamoyl phosphate with ornithine to make what?BackCitrulline (in the mitochondria ; then exported to the cytosol). OTC deficiency is the most common inherited urea cycle disorder — X-linked recessive .
- FrontUrea cycle Reaction 2: which enzyme adds the second nitrogen , from what donor, at what ATP cost?BackArgininosuccinate synthetase joins citrulline + aspartate → argininosuccinate , using 1 ATP → AMP + PPi (= 2 ATP equivalents ). Aspartate donates the cycle's 2nd nitrogen.
- FrontReaction 3: argininosuccinase cleaves argininosuccinate into which two products, and why is one of them special?BackArginine + fumarate . Fumarate is a direct TCA cycle intermediate → links the urea cycle to the TCA cycle (→ malate → oxaloacetate → aspartate, regenerating the 2nd N donor).
- FrontReaction 4 — the only step that directly produces urea: which enzyme, and what else is regenerated?BackArginase hydrolyzes arginine → urea + ornithine . Ornithine re-enters the mitochondria to restart the cycle.
- FrontWhere do the two nitrogens in urea come from? (Name both, precisely.)BackOne from NH4+ (via carbamoyl phosphate, Rxn 1); one from aspartate (Rxn 2). NOT from glutamine, and NOT two NH4+.
- FrontWhat is the total ATP cost per molecule of urea, and how is it split?Back4 ATP equivalents : 2 ATP at CPS-I + 2 equivalents (ATP → AMP + PPi) at argininosuccinate synthetase . Occurs in the liver .
- FrontPPP oxidative phase: which enzyme is the rate-limiting / committed step?BackGlucose-6-phosphate dehydrogenase (G6PD) — the irreversible, regulated gate; G6PD oxidizes glucose-6-phosphate → 6-phosphogluconolactone .
- FrontWhat is the regulator of G6PD activity (the PPP rate-limiting step)?BackThe NADPH/NADP+ ratio — G6PD is product-inhibited by NADPH ; it accelerates when NADP+ rises (biosynthesis / oxidative stress). NOT ATP/AMP as in glycolysis.
- FrontPer glucose-6-phosphate through the oxidative phase, exactly what is produced? (count the NADPH, the sugar, the CO2, the ATP)Back2 NADPH + 1 ribose-5-phosphate + 1 CO 2 ; no ATP is made.
- FrontThe two PPP products and their roles: NADPH is for ___ ; ribose-5-phosphate is for ___ ?BackNADPH = reducing power for biosynthesis + antioxidant defense . Ribose-5-phosphate = the sugar backbone for nucleotide synthesis .
- FrontAntioxidant chain — which enzyme uses NADPH to regenerate reduced glutathione (GSH) from GSSG ?BackGlutathione reductase ( enzyme ) — uses NADPH as the electron donor: GSSG → 2 GSH .
- FrontWhich enzyme uses GSH to actually neutralize H₂O₂ / ROS?BackGlutathione peroxidase — GSH → GSSG while reducing H 2 O 2 to water. ( Glutathione reductase then restores GSH using NADPH .)
- FrontWhy are erythrocytes uniquely dependent on the PPP for antioxidant defense?BackThey have no mitochondria — so the PPP is their only source of NADPH , hence their only way to regenerate GSH and fight oxidative stress.
- FrontG6PD deficiency — what disease results, and what hallmark RBC finding?BackHemolytic anemia with Heinz bodies (precipitated, oxidized hemoglobin). Episodic, oxidant-triggered — not continuous.
- FrontG6PD deficiency : name the classic oxidative triggers of hemolysis.BackFava beans (favism), oxidant drugs ( primaquine , dapsone, nitrofurantoin), and infection . Patients are asymptomatic at rest ; hemolysis appears 1–3 days after the trigger.
- FrontG6PD deficiency — inheritance pattern and who is predominantly affected?BackX-linked — males predominantly affected. It is the most common human enzyme deficiency worldwide (~400 million).
- FrontWalk the broken chain in G6PD deficiency : no G6PD → ? → ? → hemolysis.BackNo G6PD → no NADPH → glutathione reductase cannot regenerate GSH → ROS accumulate → oxidize Hb ( Heinz bodies ) + membrane → hemolysis .
- FrontWhich process does NOT require NADPH ? — fatty acid synthesis, cholesterol synthesis, steroid hormone synthesis, β-oxidationBackβ-oxidation — it instead produces FADH 2 and NADH . The other three (all biosynthetic) require NADPH . Classic trap: synthesis vs breakdown.
- FrontBesides GSH regeneration and fatty-acid/cholesterol synthesis, name two more major NADPH uses.BackRibonucleotide reductase (ribonucleotides → deoxyribonucleotides for DNA) and cytochrome P450 detoxification of drugs/xenobiotics ( liver ).
- FrontOxidative-phase step 2 (hydrolysis of 6-phosphogluconolactone) is catalyzed by which enzyme? What is the planted distractor?Back6-phosphogluconolactonase ( enzyme ) → 6-phosphogluconate . Trap = phosphohexose isomerase , which is a glycolysis enzyme.
- FrontHow can a cell make ribose-5-phosphate when it has abundant NADPH and doesn't need the oxidative phase?BackRun the non-oxidative phase in REVERSE : transketolase + transaldolase pull fructose-6-phosphate + glyceraldehyde-3-phosphate → ribose-5-P. No NADPH made — NADPH is exclusive to the irreversible oxidative phase.
- FrontWhich non-oxidative PPP enzyme requires a vitamin-derived cofactor , and what is it?BackTransketolase requires thiamine pyrophosphate (TPP) — vitamin B1. (Thiamine deficiency → beriberi / Wernicke's impairs this phase.)
- FrontWhat is the rate-limiting enzyme of cholesterol synthesis?BackHMG-CoA reductase (converts HMG-CoA → mevalonate )
- FrontHMG-CoA reductase reduces HMG-CoA to mevalonate using which cofactor ?BackNADPH (2 molecules)
- FrontIn which compartment does cholesterol synthesis occur?BackCytosol (and ER for the final cyclization stage) — not mitochondria
- FrontWhich drug class are competitive inhibitors of HMG-CoA reductase ?BackStatins (e.g., lovastatin, atorvastatin ) — they structurally mimic HMG-CoA
- FrontBy depleting hepatic cholesterol, statins indirectly upregulate which cell-surface receptor — lowering plasma LDL?BackLDL receptors on hepatocytes (via SREBP ), pulling LDL out of blood
- FrontHMG-CoA reductase is active in which phosphorylation state?BackDephosphorylated = active ; phosphorylated = inactive
- FrontWhich kinase phosphorylates (inactivates) HMG-CoA reductase during energy deficit?BackAMPK (activated by a high AMP:ATP ratio)
- FrontWhich hormone activates HMG-CoA reductase (promotes dephosphorylation, fed state)?BackInsulin — drives the fed/anabolic state
- FrontWhich hormone inhibits HMG-CoA reductase (promotes phosphorylation, fasting)?BackGlucagon — suppresses cholesterol synthesis when fasting
- FrontCholesterol itself feedback-inhibits its own synthesis through which transcription factor pathway?BackSREBP (Sterol Regulatory Element Binding Protein) — high cholesterol retains SREBP-SCAP in the ER , so the reductase gene is not transcribed
- FrontWhen intracellular cholesterol is LOW , what does the SREBP-SCAP complex do?BackReleased from the ER → travels to Golgi → cleaved by S2P → SREBP domain enters nucleus → upregulates HMG-CoA reductase + LDL receptor genes
- FrontName the THREE independent mechanisms that regulate HMG-CoA reductase .Back(1) Phosphorylation (covalent), (2) SREBP transcription , (3) proteasomal degradation of the enzyme (triggered by excess cholesterol + bile acids)
- FrontCholesterol synthesis happens in the cytosol, but acetyl-CoA is made in the mitochondria — and acetyl-CoA cannot cross the inner membrane . How does it reach the cytosol?BackThe citrate shuttle : acetyl-CoA + OAA → citrate (exported), then cleaved back to cytosolic acetyl-CoA
- FrontWhich enzyme regenerates cytosolic acetyl-CoA from citrate (consuming 1 ATP)?BackATP-citrate lyase (citrate → acetyl-CoA + OAA)
- FrontCytosolic HMG-CoA commits to which pathway?BackCholesterol synthesis (via HMG-CoA reductase → mevalonate)
- FrontMitochondrial HMG-CoA commits to which pathway, and via which enzyme?BackKetogenesis — via HMG-CoA lyase (NOT reductase)
- FrontHMG-CoA → mevalonate by HMG-CoA reductase. Which pathway / compartment is this?BackCholesterol synthesis in the cytosol
- FrontHMG-CoA → acetoacetate + acetyl-CoA by HMG-CoA lyase. Which pathway / compartment is this?BackKetogenesis in the mitochondria (liver)
- FrontB1 (thiamine) → which active cofactor , and what reaction type does it run?BackB1 thiamine → TPP (thiamine pyrophosphate) ; runs oxidative decarboxylation — pyruvate dehydrogenase , α-ketoglutarate dehydrogenase , and transketolase .
- FrontWhich cofactor /vitamin is required by the PDH , α-KG dehydrogenase , and transketolase reactions?BackTPP (thiamine pyrophosphate), the active form of vitamin B1 / thiamine . Mnemonic: TPP runs oxidative decarboxylations .
- FrontB2 (riboflavin) → which two active cofactors , and what chemistry do they do?BackB2 riboflavin → FAD and FMN ; flavin redox carriers in oxidoreductases (FAD accepts 2e − + 2H + → FADH 2 ).
- FrontAn enzyme needs FAD/FMN . Which vitamin is the precursor?BackVitamin B2 (riboflavin) . (Contrast: NAD+/NADP+ come from B3 , not B2.)
- FrontB3 (niacin) → which active cofactors , and what reaction type?BackB3 niacin / nicotinamide → NAD + and NADP + ; hydride (H − ) redox carriers in dehydrogenases (NAD + takes 2e − + 1H + → NADH).
- FrontWhich vitamin gives rise to NAD + and NADP + ?BackVitamin B3 (niacin) . (Bonus: tryptophan can also be converted to nicotinamide for NAD + /NADP + .)
- FrontB5 (pantothenate) → which active cofactor , and what does it carry?BackB5 pantothenic acid → Coenzyme A (CoA) ; carries acyl groups (e.g. acetyl-CoA ) — the acyl-transfer cofactor of transferases .
- FrontWhich vitamin is the precursor of Coenzyme A ?BackVitamin B5 (pantothenic acid) — CoA carries acyl groups .
- FrontB6 (pyridoxine) → which active cofactor , and what is its signature reaction type?BackB6 pyridoxine → PLP (pyridoxal phosphate) ; signature reaction = transamination (also decarboxylations → bioamines). "Moving, removing, or making a bioamine from an amino acid" = PLP .
- FrontA transaminase (e.g. ALT, AST) requires which cofactor , derived from which vitamin?BackPLP (pyridoxal phosphate) , from vitamin B6 . The amino group is shuttled onto α-ketoglutarate → glutamate via a ping-pong mechanism.
- FrontB7 (biotin) → what reaction type, and name its two flagship enzymes ?BackB7 biotin = CO 2 carrier for carboxylations (ATP-dependent); flagship pyruvate carboxylase and acetyl-CoA carboxylase (ACC) . Covalently bound = prosthetic group .
- FrontWhich vitamin acts as the covalently-bound CO 2 carrier in carboxylase reactions?BackBiotin (vitamin B7) — e.g. pyruvate + CO 2 + ATP → oxaloacetate (pyruvate carboxylase).
- FrontB9 (folate) → which active cofactor , and what does it carry?BackB9 folate → THF (tetrahydrofolate) ; carries one-carbon units for nucleotide synthesis (dTMP) and homocysteine remethylation. (Folate → DHF → THF by DHFR .)
- FrontThe Ser→Gly reaction loads which exact one-carbon form onto THF , and what uses it?BackLoads N5,N10-methylene-THF — the major one-carbon source. Used by thymidylate synthase : dUMP → dTMP (then THF is oxidized to DHF). Folate deficiency → no dTMP → megaloblastic anemia.
- FrontB12 (cobalamin) is required for exactly which two enzymes ?BackMethionine synthase (methylcobalamin; homocysteine + 5-methyl-THF → methionine ) and methylmalonyl-CoA mutase (5'-deoxyadenosylcobalamin; methylmalonyl-CoA → succinyl-CoA ).
- FrontWhich enzyme converts methylmalonyl-CoA → succinyl-CoA , and which cofactor/form does it use?BackMethylmalonyl-CoA mutase , using 5'-deoxyadenosylcobalamin (B12) . B12 deficiency → methylmalonic aciduria (most sensitive marker).
- FrontVitamin K → what reaction type, and on which proteins?BackVitamin K = cofactor for γ-carboxylation of glutamate residues on γ-glutamyl carboxylase 's substrates — the clotting factors II, VII, IX, X (and proteins C, S). Creates Ca 2+ -binding Gla residues.
- FrontDistinguish the role of biotin vs vitamin K — both touch CO 2 /carboxyl chemistry. Which does which?BackBiotin = carries CO 2 to add a NEW carboxyl in ATP-dependent carboxylases (pyruvate carboxylase, ACC). Vitamin K = γ-carboxylates EXISTING Glu residues on clotting factors — no CO 2 -carrier role, no ATP .
- FrontReplication: which enzyme unwinds the double helix at the fork by breaking base-pair H-bonds (ATP-driven)?BackDNA helicase — uses ATP hydrolysis to break the hydrogen bonds between base pairs and open the fork.
- FrontReplication: which enzyme lays down the short RNA primer that DNA polymerase needs to start?BackPrimase — it is an RNA polymerase that makes a ~10-nt RNA primer providing the free 3'-OH. (In eukaryotes the primase subunit of DNA pol α .)
- FrontReplication: which enzyme synthesizes the new strand, and in which direction?BackDNA polymerase — adds nucleotides only 5'→3' (reading template 3'→5'). It cannot start de novo — needs a primer with a free 3'-OH.
- FrontWhich exonuclease activity does DNA polymerase use to proofread , and which direction does it run?BackIts 3'→5' exonuclease — backs up 3'→5', excises the mispaired nucleotide, and reinserts the correct one. Note: DNA pol α lacks this proofreading.
- FrontReplication: which enzyme seals the nicks between Okazaki fragments after primer removal?BackDNA ligase — forms the phosphodiester bond at the cost of ATP (eukaryotes) / NAD+ (bacteria). It joins pre-existing strands — it cannot synthesize DNA de novo.
- FrontReplication: which enzyme relieves the positive supercoils generated ahead of the fork?BackTopoisomerase — relaxes supercoiling . Type I cuts one strand; Type II cuts both strands (and can unlink catenanes).
- FrontReplication: which enzyme extends the chromosome ends to solve the end-replication problem?BackTelomerase — a reverse transcriptase carrying its own RNA template ; it extends the 3' end of the parental strand . Active in stem/cancer cells ; low/absent in most somatic cells .
- FrontMatch the function → enzyme: seals nicks · unwinds helix · lays RNA primer · relieves supercoilsBackseals nicks = ligase · unwinds = helicase · lays primer = primase · relieves supercoils = topoisomerase .
- FrontReplication TRAP: DNA polymerase needs a primer to start — but does RNA polymerase (transcription) need one?BackNo — RNA polymerase needs NO primer. It can initiate synthesis de novo. Only DNA polymerase requires a primer (a free 3'-OH from primase ).
- FrontWhich replication enzyme functions WITHOUT needing a pre-existing 3'-OH primer — DNA polymerase or primase/RNA polymerase?BackPrimase / RNA polymerase — these synthesize RNA de novo , no primer required. DNA polymerase always needs a primer.
- FrontTranslation: which ribosome site receives the incoming aminoacyl-tRNA ?BackThe A site (aminoacyl site) — accepts each new incoming aminoacyl-tRNA (delivered by eEF1A, 1 GTP).
- FrontTranslation: which ribosome site holds the peptidyl-tRNA (the tRNA carrying the growing chain)?BackThe P site (peptidyl site) — holds the peptidyl-tRNA bearing the growing polypeptide.
- FrontTranslation: which ribosome site is where the uncharged tRNA exits ?BackThe E site (exit site) — the empty/uncharged tRNA leaves here after its amino acid has been transferred.
- FrontMatch: incoming aminoacyl-tRNA · peptidyl-tRNA (growing chain) · uncharged tRNA exits → which ribosome site each?Backincoming aminoacyl-tRNA = A site · peptidyl-tRNA = P site · uncharged tRNA exits = E site . Ribosome moves 5'→3' along mRNA.
- FrontTranslation: which activity forms the peptide bond , and what is it chemically made of?BackPeptidyl transferase — it is the rRNA of the large subunit , i.e. a ribozyme (not a protein). Eukaryote: 28S rRNA ; prokaryote: 23S rRNA .
- FrontPeptidyl transferase is a ribozyme — what does "ribozyme" mean here, and what does it catalyze?BackAn RNA enzyme — the catalytic rRNA (28S/23S) of the large subunit catalyzes peptide bond formation between the A-site and P-site amino acids. The ribosomal proteins are scaffolding, not the catalyst .
Study these 166 cards with spaced repetition. Klappa is a free flashcard app: it schedules every card with FSRS-6, studies a deck as flashcards, multiple choice, typed answers or a graded test, and imports your Anki decks. How Klappa schedules reviews.